img

Global and India Biopharmaceutical CDMO Market Report & Forecast 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global and India Biopharmaceutical CDMO Market Report & Forecast 2024-2034

The global Biopharmaceutical CDMO revenue was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the review period (2023-2033).
In India the Biopharmaceutical CDMO revenue is expected to grow from US$ million in 2022 to US$ million by 2033, at a CAGR of % during the forecast period 2023-2033.
The global key players of Biopharmaceutical CDMO include Lonza, WuXi AppTec, Catalent, Thermo Fisher, Recipharm, Samsung Biologics, Siegfried, Delpharm and Boehringer Ingelheim, etc. The global five biggest players hold a share of % in 2022.
This report focuses on global and India Biopharmaceutical CDMO market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Biopharmaceutical CDMO will continue to grow rapidly in the future.
Global Biopharmaceutical CDMO Scope and Market Size
Biopharmaceutical CDMO market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Biopharmaceutical CDMO market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For India market, this report focuses on the Biopharmaceutical CDMO market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in India.



By Company


Lonza
WuXi AppTec
Catalent
Thermo Fisher
Recipharm
Samsung Biologics
Siegfried
Delpharm
Boehringer Ingelheim
Aenova Group
AGC Parma Chemicals
GenScript
ProBioGen
KBI Biopharma
3P Biopharmaceuticals
Rentschler Biopharma
Northway Biotech
Segment by Type
Development and Manufacturing CDMOs
Clinical Trial Material CDMOs
Fill-Finish CDMOs
Other

Segment by Application


Pharmaceutical Company
Biotechnology Company
Other
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Biopharmaceutical CDMO definition, global market size, India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Biopharmaceutical CDMO companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Biopharmaceutical CDMO in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biopharmaceutical CDMO revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions

Table of Content

1 Study Coverage
1.1 Biopharmaceutical CDMO Product Introduction
1.2 Global Biopharmaceutical CDMO Outlook 2018 VS 2022 VS 2033
1.2.1 Global Biopharmaceutical CDMO Market Size for the Year 2018-2033
1.2.2 India Biopharmaceutical CDMO Market Size for the Year 2018-2033
1.3 Biopharmaceutical CDMO Market Size, India VS Global, 2018 VS 2022 VS 2033
1.3.1 The Market Share of India Biopharmaceutical CDMO in Global, 2018 VS 2022 VS 2033
1.3.2 The Growth Rate of Biopharmaceutical CDMO Market Size, India VS Global, 2018 VS 2022 VS 2033
1.4 Biopharmaceutical CDMO Market Dynamics
1.4.1 Biopharmaceutical CDMO Industry Trends
1.4.2 Biopharmaceutical CDMO Market Drivers
1.4.3 Biopharmaceutical CDMO Market Challenges
1.4.4 Biopharmaceutical CDMO Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Biopharmaceutical CDMO by Type
2.1 Biopharmaceutical CDMO Market Segment by Type
2.1.1 Development and Manufacturing CDMOs
2.1.2 Clinical Trial Material CDMOs
2.1.3 Fill-Finish CDMOs
2.1.4 Other
2.2 Global Biopharmaceutical CDMO Market Size by Type (2018, 2022 & 2033)
2.3 Global Biopharmaceutical CDMO Market Size by Type (2018-2033)
2.4 India Biopharmaceutical CDMO Market Size by Type (2018, 2022 & 2033)
2.5 India Biopharmaceutical CDMO Market Size by Type (2018-2033)
3 Biopharmaceutical CDMO by Application
3.1 Biopharmaceutical CDMO Market Segment by Application
3.1.1 Pharmaceutical Company
3.1.2 Biotechnology Company
3.1.3 Other
3.2 Global Biopharmaceutical CDMO Market Size by Application (2018, 2022 & 2033)
3.3 Global Biopharmaceutical CDMO Market Size by Application (2018-2033)
3.4 India Biopharmaceutical CDMO Market Size by Application (2018, 2022 & 2033)
3.5 India Biopharmaceutical CDMO Market Size by Application (2018-2033)
4 Global Biopharmaceutical CDMO Competitor Landscape by Company
4.1 Global Biopharmaceutical CDMO Market Size by Company
4.1.1 Global Key Companies of Biopharmaceutical CDMO, Ranked by Revenue (2022)
4.1.2 Global Biopharmaceutical CDMO Revenue by Player (2018-2023)
4.2 Global Biopharmaceutical CDMO Concentration Ratio (CR)
4.2.1 Biopharmaceutical CDMO Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Biopharmaceutical CDMO in 2022
4.2.3 Global Biopharmaceutical CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Biopharmaceutical CDMO Head office and Area Served
4.4 Global Key Players of Biopharmaceutical CDMO, Product and Application
4.5 Global Key Players of Biopharmaceutical CDMO, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 India Biopharmaceutical CDMO Market Size by Company
4.7.1 Key Players of Biopharmaceutical CDMO in India, Ranked by Revenue (2022)
4.7.2 India Biopharmaceutical CDMO Revenue by Players (2021, 2022 & 2023)
5 Global Biopharmaceutical CDMO Market Size by Region
5.1 Global Biopharmaceutical CDMO Market Size by Region: 2018 VS 2022 VS 2033
5.2 Global Biopharmaceutical CDMO Market Size by Region (2018-2033)
5.2.1 Global Biopharmaceutical CDMO Market Size by Region: 2018-2023
5.2.2 Global Biopharmaceutical CDMO Market Size by Region (2024-2033)
6 Americas
6.1 Americas Biopharmaceutical CDMO Market Size YoY Growth 2018-2033
6.2 Americas Biopharmaceutical CDMO Market Size by Type
6.2.1 Americas Biopharmaceutical CDMO Market Size by Type (2018-2023)
6.2.2 Americas Biopharmaceutical CDMO Market Size by Type (2024-2033)
6.2.3 Americas Biopharmaceutical CDMO Market Share by Type (2018-2033)
6.3 Americas Biopharmaceutical CDMO Market Size by Application
6.3.1 Americas Biopharmaceutical CDMO Market Size by Application (2018-2023)
6.3.2 Americas Biopharmaceutical CDMO Market Size by Application (2024-2033)
6.3.3 Americas Biopharmaceutical CDMO Market Share by Application (2018-2033)
6.4 Americas Biopharmaceutical CDMO Market Facts & Figures by Country (2018, 2022 & 2033)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Biopharmaceutical CDMO Market Size YoY Growth 2018-2033
7.2 EMEA Biopharmaceutical CDMO Market Size by Type
7.2.1 EMEA Biopharmaceutical CDMO Market Size by Type (2018-2023)
7.2.2 EMEA Biopharmaceutical CDMO Market Size by Type (2024-2033)
7.2.3 EMEA Biopharmaceutical CDMO Market Share by Type (2018-2033)
7.3 EMEA Biopharmaceutical CDMO Market Size by Application
7.3.1 EMEA Biopharmaceutical CDMO Market Size by Application (2018-2023)
7.3.2 EMEA Biopharmaceutical CDMO Market Size by Application (2024-2033)
7.3.3 EMEA Biopharmaceutical CDMO Market Share by Application (2018-2033)
7.4 EMEA Biopharmaceutical CDMO Market Facts & Figures by Country (2018, 2022 & 2033)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Biopharmaceutical CDMO Market Size YoY Growth 2018-2033
8.2 China Biopharmaceutical CDMO Market Size by Type
8.2.1 China Biopharmaceutical CDMO Market Size by Type (2018-2023)
8.2.2 China Biopharmaceutical CDMO Market Size by Type (2024-2033)
8.2.3 China Biopharmaceutical CDMO Market Share by Type (2018-2033)
8.3 China Biopharmaceutical CDMO Market Size by Application
8.3.1 China Biopharmaceutical CDMO Market Size by Application (2018-2023)
8.3.2 China Biopharmaceutical CDMO Market Size by Application (2024-2033)
8.3.3 China Biopharmaceutical CDMO Market Share by Application (2018-2033)
9 APAC (excluding China)
9.1 APAC Biopharmaceutical CDMO Market Size YoY Growth 2018-2033
9.2 APAC Biopharmaceutical CDMO Market Size by Type
9.2.1 APAC Biopharmaceutical CDMO Market Size by Type (2018-2023)
9.2.2 APAC Biopharmaceutical CDMO Market Size by Type (2024-2033)
9.2.3 APAC Biopharmaceutical CDMO Market Share by Type (2018-2033)
9.3 APAC Biopharmaceutical CDMO Market Size by Application
9.3.1 APAC Biopharmaceutical CDMO Market Size by Application (2018-2023)
9.3.2 APAC Biopharmaceutical CDMO Market Size by Application (2024-2033)
9.3.3 APAC Biopharmaceutical CDMO Market Share by Application (2018-2033)
9.4 APAC Biopharmaceutical CDMO Market Facts & Figures by Country (2018, 2022 & 2033)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Lonza
10.1.1 Lonza Company Details
10.1.2 Lonza Business Overview
10.1.3 Lonza Biopharmaceutical CDMO Introduction
10.1.4 Lonza Revenue in Biopharmaceutical CDMO Business (2018-2023)
10.1.5 Lonza Recent Development
10.2 WuXi AppTec
10.2.1 WuXi AppTec Company Details
10.2.2 WuXi AppTec Business Overview
10.2.3 WuXi AppTec Biopharmaceutical CDMO Introduction
10.2.4 WuXi AppTec Revenue in Biopharmaceutical CDMO Business (2018-2023)
10.2.5 WuXi AppTec Recent Development
10.3 Catalent
10.3.1 Catalent Company Details
10.3.2 Catalent Business Overview
10.3.3 Catalent Biopharmaceutical CDMO Introduction
10.3.4 Catalent Revenue in Biopharmaceutical CDMO Business (2018-2023)
10.3.5 Catalent Recent Development
10.4 Thermo Fisher
10.4.1 Thermo Fisher Company Details
10.4.2 Thermo Fisher Business Overview
10.4.3 Thermo Fisher Biopharmaceutical CDMO Introduction
10.4.4 Thermo Fisher Revenue in Biopharmaceutical CDMO Business (2018-2023)
10.4.5 Thermo Fisher Recent Development
10.5 Recipharm
10.5.1 Recipharm Company Details
10.5.2 Recipharm Business Overview
10.5.3 Recipharm Biopharmaceutical CDMO Introduction
10.5.4 Recipharm Revenue in Biopharmaceutical CDMO Business (2018-2023)
10.5.5 Recipharm Recent Development
10.6 Samsung Biologics
10.6.1 Samsung Biologics Company Details
10.6.2 Samsung Biologics Business Overview
10.6.3 Samsung Biologics Biopharmaceutical CDMO Introduction
10.6.4 Samsung Biologics Revenue in Biopharmaceutical CDMO Business (2018-2023)
10.6.5 Samsung Biologics Recent Development
10.7 Siegfried
10.7.1 Siegfried Company Details
10.7.2 Siegfried Business Overview
10.7.3 Siegfried Biopharmaceutical CDMO Introduction
10.7.4 Siegfried Revenue in Biopharmaceutical CDMO Business (2018-2023)
10.7.5 Siegfried Recent Development
10.8 Delpharm
10.8.1 Delpharm Company Details
10.8.2 Delpharm Business Overview
10.8.3 Delpharm Biopharmaceutical CDMO Introduction
10.8.4 Delpharm Revenue in Biopharmaceutical CDMO Business (2018-2023)
10.8.5 Delpharm Recent Development
10.9 Boehringer Ingelheim
10.9.1 Boehringer Ingelheim Company Details
10.9.2 Boehringer Ingelheim Business Overview
10.9.3 Boehringer Ingelheim Biopharmaceutical CDMO Introduction
10.9.4 Boehringer Ingelheim Revenue in Biopharmaceutical CDMO Business (2018-2023)
10.9.5 Boehringer Ingelheim Recent Development
10.10 Aenova Group
10.10.1 Aenova Group Company Details
10.10.2 Aenova Group Business Overview
10.10.3 Aenova Group Biopharmaceutical CDMO Introduction
10.10.4 Aenova Group Revenue in Biopharmaceutical CDMO Business (2018-2023)
10.10.5 Aenova Group Recent Development
10.11 AGC Parma Chemicals
10.11.1 AGC Parma Chemicals Company Details
10.11.2 AGC Parma Chemicals Business Overview
10.11.3 AGC Parma Chemicals Biopharmaceutical CDMO Introduction
10.11.4 AGC Parma Chemicals Revenue in Biopharmaceutical CDMO Business (2018-2023)
10.11.5 AGC Parma Chemicals Recent Development
10.12 GenScript
10.12.1 GenScript Company Details
10.12.2 GenScript Business Overview
10.12.3 GenScript Biopharmaceutical CDMO Introduction
10.12.4 GenScript Revenue in Biopharmaceutical CDMO Business (2018-2023)
10.12.5 GenScript Recent Development
10.13 ProBioGen
10.13.1 ProBioGen Company Details
10.13.2 ProBioGen Business Overview
10.13.3 ProBioGen Biopharmaceutical CDMO Introduction
10.13.4 ProBioGen Revenue in Biopharmaceutical CDMO Business (2018-2023)
10.13.5 ProBioGen Recent Development
10.14 KBI Biopharma
10.14.1 KBI Biopharma Company Details
10.14.2 KBI Biopharma Business Overview
10.14.3 KBI Biopharma Biopharmaceutical CDMO Introduction
10.14.4 KBI Biopharma Revenue in Biopharmaceutical CDMO Business (2018-2023)
10.14.5 KBI Biopharma Recent Development
10.15 3P Biopharmaceuticals
10.15.1 3P Biopharmaceuticals Company Details
10.15.2 3P Biopharmaceuticals Business Overview
10.15.3 3P Biopharmaceuticals Biopharmaceutical CDMO Introduction
10.15.4 3P Biopharmaceuticals Revenue in Biopharmaceutical CDMO Business (2018-2023)
10.15.5 3P Biopharmaceuticals Recent Development
10.16 Rentschler Biopharma
10.16.1 Rentschler Biopharma Company Details
10.16.2 Rentschler Biopharma Business Overview
10.16.3 Rentschler Biopharma Biopharmaceutical CDMO Introduction
10.16.4 Rentschler Biopharma Revenue in Biopharmaceutical CDMO Business (2018-2023)
10.16.5 Rentschler Biopharma Recent Development
10.17 Northway Biotech
10.17.1 Northway Biotech Company Details
10.17.2 Northway Biotech Business Overview
10.17.3 Northway Biotech Biopharmaceutical CDMO Introduction
10.17.4 Northway Biotech Revenue in Biopharmaceutical CDMO Business (2018-2023)
10.17.5 Northway Biotech Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. Biopharmaceutical CDMO Market Size India VS Global, CAGR (2018 VS 2022 VS 2033)
Table 2. Biopharmaceutical CDMO Market Trends
Table 3. Biopharmaceutical CDMO Market Drivers
Table 4. Biopharmaceutical CDMO Market Challenges
Table 5. Biopharmaceutical CDMO Market Restraints
Table 6. Global Biopharmaceutical CDMO Market Size by Type: 2018 VS 2022 VS 2033 (US$ Million)
Table 7. India Biopharmaceutical CDMO Market Size by Type: 2018 VS 2022 VS 2033 (US$ Million)
Table 8. Global Biopharmaceutical CDMO Market Size by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 9. India Biopharmaceutical CDMO Market Size by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 10. Global Key Companies of Biopharmaceutical CDMO, Ranked by Revenue (2022) & (US$ Million)
Table 11. Global Biopharmaceutical CDMO Revenue by Player, (US$ Million), 2018-2023
Table 12. Global Biopharmaceutical CDMO Revenue Share by Player, 2018-2023
Table 13. Global Biopharmaceutical CDMO Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Biopharmaceutical CDMO by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical CDMO as of 2022)
Table 15. Global Key Players of Biopharmaceutical CDMO, Headquarters and Area Served
Table 16. Global Key Players of Biopharmaceutical CDMO, Product and Application
Table 17. Global Key Players of Biopharmaceutical CDMO, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Biopharmaceutical CDMO in India, Ranked by Revenue (2022) & (US$ Million)
Table 20. India Biopharmaceutical CDMO Revenue by Players, (US$ Million), 2021, 2022 & 2023
Table 21. India Biopharmaceutical CDMO Revenue Share by Players, 2021, 2022 & 2023
Table 22. Global Biopharmaceutical CDMO Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 23. Global Biopharmaceutical CDMO Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global Biopharmaceutical CDMO Market Size Forecast by Region (2024-2033) & (US$ Million)
Table 25. Americas Biopharmaceutical CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 26. Americas Biopharmaceutical CDMO Market Size by Type (2024-2033) & (US$ Million)
Table 27. Americas Biopharmaceutical CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas Biopharmaceutical CDMO Market Size by Application (2024-2033) & (US$ Million)
Table 29. Americas Biopharmaceutical CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 30. Americas Biopharmaceutical CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas Biopharmaceutical CDMO Market Size by Country (2024-2033) & (US$ Million)
Table 32. EMEA Biopharmaceutical CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 33. EMEA Biopharmaceutical CDMO Market Size by Type (2024-2033) & (US$ Million)
Table 34. EMEA Biopharmaceutical CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA Biopharmaceutical CDMO Market Size by Application (2024-2033) & (US$ Million)
Table 36. EMEA Biopharmaceutical CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. EMEA Biopharmaceutical CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA Biopharmaceutical CDMO Market Size by Country (2024-2033) & (US$ Million)
Table 39. China Biopharmaceutical CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 40. China Biopharmaceutical CDMO Market Size by Type (2024-2033) & (US$ Million)
Table 41. China Biopharmaceutical CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 42. China Biopharmaceutical CDMO Market Size by Application (2024-2033) & (US$ Million)
Table 43. China Biopharmaceutical CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. APAC Biopharmaceutical CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 45. APAC Biopharmaceutical CDMO Market Size by Type (2024-2033) & (US$ Million)
Table 46. APAC Biopharmaceutical CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC Biopharmaceutical CDMO Market Size by Application (2024-2033) & (US$ Million)
Table 48. APAC Biopharmaceutical CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 49. APAC Biopharmaceutical CDMO Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC Biopharmaceutical CDMO Market Size by Region (2024-2033) & (US$ Million)
Table 51. Lonza Company Details
Table 52. Lonza Business Overview
Table 53. Lonza Biopharmaceutical CDMO Product
Table 54. Lonza Revenue in Biopharmaceutical CDMO Business (2018-2023) & (US$ Million)
Table 55. Lonza Recent Development
Table 56. WuXi AppTec Company Details
Table 57. WuXi AppTec Business Overview
Table 58. WuXi AppTec Biopharmaceutical CDMO Product
Table 59. WuXi AppTec Revenue in Biopharmaceutical CDMO Business (2018-2023) & (US$ Million)
Table 60. WuXi AppTec Recent Development
Table 61. Catalent Company Details
Table 62. Catalent Business Overview
Table 63. Catalent Biopharmaceutical CDMO Product
Table 64. Catalent Revenue in Biopharmaceutical CDMO Business (2018-2023) & (US$ Million)
Table 65. Catalent Recent Development
Table 66. Thermo Fisher Company Details
Table 67. Thermo Fisher Business Overview
Table 68. Thermo Fisher Biopharmaceutical CDMO Product
Table 69. Thermo Fisher Revenue in Biopharmaceutical CDMO Business (2018-2023) & (US$ Million)
Table 70. Thermo Fisher Recent Development
Table 71. Recipharm Company Details
Table 72. Recipharm Business Overview
Table 73. Recipharm Biopharmaceutical CDMO Product
Table 74. Recipharm Revenue in Biopharmaceutical CDMO Business (2018-2023) & (US$ Million)
Table 75. Recipharm Recent Development
Table 76. Samsung Biologics Company Details
Table 77. Samsung Biologics Business Overview
Table 78. Samsung Biologics Biopharmaceutical CDMO Product
Table 79. Samsung Biologics Revenue in Biopharmaceutical CDMO Business (2018-2023) & (US$ Million)
Table 80. Samsung Biologics Recent Development
Table 81. Siegfried Company Details
Table 82. Siegfried Business Overview
Table 83. Siegfried Biopharmaceutical CDMO Product
Table 84. Siegfried Revenue in Biopharmaceutical CDMO Business (2018-2023) & (US$ Million)
Table 85. Siegfried Recent Development
Table 86. Delpharm Company Details
Table 87. Delpharm Business Overview
Table 88. Delpharm Biopharmaceutical CDMO Product
Table 89. Delpharm Revenue in Biopharmaceutical CDMO Business (2018-2023) & (US$ Million)
Table 90. Delpharm Recent Development
Table 91. Boehringer Ingelheim Company Details
Table 92. Boehringer Ingelheim Business Overview
Table 93. Boehringer Ingelheim Biopharmaceutical CDMO Product
Table 94. Boehringer Ingelheim Revenue in Biopharmaceutical CDMO Business (2018-2023) & (US$ Million)
Table 95. Boehringer Ingelheim Recent Development
Table 96. Aenova Group Company Details
Table 97. Aenova Group Business Overview
Table 98. Aenova Group Biopharmaceutical CDMO Product
Table 99. Aenova Group Revenue in Biopharmaceutical CDMO Business (2018-2023) & (US$ Million)
Table 100. Aenova Group Recent Development
Table 101. AGC Parma Chemicals Company Details
Table 102. AGC Parma Chemicals Business Overview
Table 103. AGC Parma Chemicals Biopharmaceutical CDMO Product
Table 104. AGC Parma Chemicals Revenue in Biopharmaceutical CDMO Business (2018-2023) & (US$ Million)
Table 105. AGC Parma Chemicals Recent Development
Table 106. GenScript Company Details
Table 107. GenScript Business Overview
Table 108. GenScript Biopharmaceutical CDMO Product
Table 109. GenScript Revenue in Biopharmaceutical CDMO Business (2018-2023) & (US$ Million)
Table 110. GenScript Recent Development
Table 111. ProBioGen Company Details
Table 112. ProBioGen Business Overview
Table 113. ProBioGen Biopharmaceutical CDMO Product
Table 114. ProBioGen Revenue in Biopharmaceutical CDMO Business (2018-2023) & (US$ Million)
Table 115. ProBioGen Recent Development
Table 116. KBI Biopharma Company Details
Table 117. KBI Biopharma Business Overview
Table 118. KBI Biopharma Biopharmaceutical CDMO Product
Table 119. KBI Biopharma Revenue in Biopharmaceutical CDMO Business (2018-2023) & (US$ Million)
Table 120. KBI Biopharma Recent Development
Table 121. 3P Biopharmaceuticals Company Details
Table 122. 3P Biopharmaceuticals Business Overview
Table 123. 3P Biopharmaceuticals Biopharmaceutical CDMO Product
Table 124. 3P Biopharmaceuticals Revenue in Biopharmaceutical CDMO Business (2018-2023) & (US$ Million)
Table 125. 3P Biopharmaceuticals Recent Development
Table 126. Rentschler Biopharma Company Details
Table 127. Rentschler Biopharma Business Overview
Table 128. Rentschler Biopharma Biopharmaceutical CDMO Product
Table 129. Rentschler Biopharma Revenue in Biopharmaceutical CDMO Business (2018-2023) & (US$ Million)
Table 130. Rentschler Biopharma Recent Development
Table 131. Northway Biotech Company Details
Table 132. Northway Biotech Business Overview
Table 133. Northway Biotech Biopharmaceutical CDMO Product
Table 134. Northway Biotech Revenue in Biopharmaceutical CDMO Business (2018-2023) & (US$ Million)
Table 135. Northway Biotech Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Biopharmaceutical CDMO Product Picture
Figure 2. Global Biopharmaceutical CDMO Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Biopharmaceutical CDMO Market Size 2018-2033 (US$ Million)
Figure 4. India Biopharmaceutical CDMO Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 5. India Biopharmaceutical CDMO Market Size 2018-2033 (US$ Million)
Figure 6. India Biopharmaceutical CDMO Market Share in Global 2018-2033
Figure 7. Biopharmaceutical CDMO Report Years Considered
Figure 8. Product Picture of Development and Manufacturing CDMOs
Figure 9. Product Picture of Clinical Trial Material CDMOs
Figure 10. Product Picture of Fill-Finish CDMOs
Figure 11. Product Picture of Other
Figure 12. Global Biopharmaceutical CDMO Market Share by Type in 2022 & 2033
Figure 13. Global Biopharmaceutical CDMO Market Size by Type (2018-2033) & (US$ Million)
Figure 14. Global Biopharmaceutical CDMO Market Share by Type (2018-2033)
Figure 15. India Biopharmaceutical CDMO Market Share by Type in 2022 & 2033
Figure 16. India Biopharmaceutical CDMO Market Size by Type (2018-2033) & (US$ Million)
Figure 17. India Biopharmaceutical CDMO Market Share by Type (2018-2033)
Figure 18. Product Picture of Pharmaceutical Company
Figure 19. Product Picture of Biotechnology Company
Figure 20. Product Picture of Other
Figure 21. Global Biopharmaceutical CDMO Market Share by Application in 2022 & 2033
Figure 22. Global Biopharmaceutical CDMO Market Size by Application (2018-2033) & (US$ Million)
Figure 23. Global Biopharmaceutical CDMO Market Share by Application (2018-2033)
Figure 24. India Biopharmaceutical CDMO Market Share by Application in 2022 & 2033
Figure 25. India Biopharmaceutical CDMO Market Size by Application (2018-2033) & (US$ Million)
Figure 26. India Biopharmaceutical CDMO Market Share by Application (2018-2033)
Figure 27. The Top 5 and 10 Largest Companies of Biopharmaceutical CDMO in the World: Market Share by Biopharmaceutical CDMO Revenue in 2022
Figure 28. Global Biopharmaceutical CDMO Market Size Market Share by Region: 2018 VS 2022 VS 2033
Figure 29. Global Biopharmaceutical CDMO Market Share by Region (2018-2033)
Figure 30. Americas Biopharmaceutical CDMO Market Size Growth Rate 2018-2033 (US$ Million)
Figure 31. Americas Biopharmaceutical CDMO Market Share by Type (2018-2033)
Figure 32. Americas Biopharmaceutical CDMO Market Share by Application (2018-2033)
Figure 33. United States Biopharmaceutical CDMO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 34. Canada Biopharmaceutical CDMO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 35. Mexico Biopharmaceutical CDMO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 36. Brazil Biopharmaceutical CDMO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 37. EMEA Biopharmaceutical CDMO Market Size Growth Rate 2018-2033 (US$ Million)
Figure 38. EMEA Biopharmaceutical CDMO Market Share by Type (2018-2033)
Figure 39. EMEA Biopharmaceutical CDMO Market Share by Application (2018-2033)
Figure 40. Europe Biopharmaceutical CDMO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 41. Middle East Biopharmaceutical CDMO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 42. Africa Biopharmaceutical CDMO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 43. China Biopharmaceutical CDMO Market Size Growth Rate 2018-2033 (US$ Million)
Figure 44. China Biopharmaceutical CDMO Market Share by Type (2018-2033)
Figure 45. China Biopharmaceutical CDMO Market Share by Application (2018-2033)
Figure 46. APAC Biopharmaceutical CDMO Market Size Growth Rate 2018-2033 (US$ Million)
Figure 47. APAC Biopharmaceutical CDMO Market Share by Type (2018-2033)
Figure 48. APAC Biopharmaceutical CDMO Market Share by Application (2018-2033)
Figure 49. Japan Biopharmaceutical CDMO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 50. South Korea Biopharmaceutical CDMO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 51. China Taiwan Biopharmaceutical CDMO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 52. Southeast Asia Biopharmaceutical CDMO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 53. India Biopharmaceutical CDMO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 54. Lonza Revenue Growth Rate in Biopharmaceutical CDMO Business (2018-2023)
Figure 55. WuXi AppTec Revenue Growth Rate in Biopharmaceutical CDMO Business (2018-2023)
Figure 56. Catalent Revenue Growth Rate in Biopharmaceutical CDMO Business (2018-2023)
Figure 57. Thermo Fisher Revenue Growth Rate in Biopharmaceutical CDMO Business (2018-2023)
Figure 58. Recipharm Revenue Growth Rate in Biopharmaceutical CDMO Business (2018-2023)
Figure 59. Samsung Biologics Revenue Growth Rate in Biopharmaceutical CDMO Business (2018-2023)
Figure 60. Siegfried Revenue Growth Rate in Biopharmaceutical CDMO Business (2018-2023)
Figure 61. Delpharm Revenue Growth Rate in Biopharmaceutical CDMO Business (2018-2023)
Figure 62. Boehringer Ingelheim Revenue Growth Rate in Biopharmaceutical CDMO Business (2018-2023)
Figure 63. Aenova Group Revenue Growth Rate in Biopharmaceutical CDMO Business (2018-2023)
Figure 64. AGC Parma Chemicals Revenue Growth Rate in Biopharmaceutical CDMO Business (2018-2023)
Figure 65. GenScript Revenue Growth Rate in Biopharmaceutical CDMO Business (2018-2023)
Figure 66. ProBioGen Revenue Growth Rate in Biopharmaceutical CDMO Business (2018-2023)
Figure 67. KBI Biopharma Revenue Growth Rate in Biopharmaceutical CDMO Business (2018-2023)
Figure 68. 3P Biopharmaceuticals Revenue Growth Rate in Biopharmaceutical CDMO Business (2018-2023)
Figure 69. Rentschler Biopharma Revenue Growth Rate in Biopharmaceutical CDMO Business (2018-2023)
Figure 70. Northway Biotech Revenue Growth Rate in Biopharmaceutical CDMO Business (2018-2023)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries